Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inactivated Influenza Vaccine”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00283283
What this trial is testing

Comparison of Full-dose Flu Vaccine to Half-dose Flu Vaccine

Who this might be right for
Influenza
U.S. Army Medical Research and Development Command 1,316
Post-approval studies (Phase 4)Study completedNCT03023553
What this trial is testing

The Human Mucosal Immune Responses to Influenza Virus (SLVP026)

Who this might be right for
Influenza
Stanford University 13
Large-scale testing (Phase 3)Study completedNCT00391053
What this trial is testing

Immunogenicity of High-dose Inactivated, Split-virion Influenza Vaccine Versus Standard Fluzone Vaccine in the Elderly

Who this might be right for
Orthomyxoviridae InfectionInfluenzaMyxovirus Infection
Sanofi Pasteur, a Sanofi Company 3,851
Testing effectiveness (Phase 2)Study completedNCT00294099
What this trial is testing

H5 Vaccine Alone or With Aluminum Hydroxide in Elderly Adults

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 600
Post-approval studies (Phase 4)Study completedNCT01688921
What this trial is testing

Jet Injection for Influenza

Who this might be right for
Influenza, Human
PharmaJet, Inc. 1,250
Large-scale testing (Phase 3)Study completedNCT01000207
What this trial is testing

Single-blind, Dose-ranging Study of Novel Swine Influenza Virus Vaccine in Japanese Pediatric Subjects

Who this might be right for
Swine-Origin Influenza A H1N1 Virus
Novartis Vaccines 123
Not applicableEnded earlyNCT01997450
What this trial is testing

A Case Control Study of the Effectiveness of Q/LAIV Versus Inactivated Influenza Vaccine and No Vaccine in Subjects 2-17 Years of Age

Who this might be right for
Influenza Vaccine Effectiveness
MedImmune LLC 4,121
Not applicableStudy completedNCT00817661
What this trial is testing

Vitamin A and Maternal-infant Flu Vaccine Response

Who this might be right for
Influenza
International Centre for Diarrhoeal Disease Research, Bangladesh 66
Testing effectiveness (Phase 2)Study completedNCT01436370
What this trial is testing

TIV and High Dose TIV in Subjects With Rheumatoid Arthritis

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 102
Testing effectiveness (Phase 2)Study completedNCT00956761
What this trial is testing

Safety and Immunogenicity of a Surface Antigen, Inactivated, Adjuvanted With MF59C.1, Seasonal Influenza Vaccine, Formulation 2009-2010

Who this might be right for
Seasonal Influenza
Novartis 63
Post-approval studies (Phase 4)Study completedNCT02263027
What this trial is testing

Do Some Healthy Adults Consistently Have Systemic Reactions to Influenza Vaccines?

Who this might be right for
Influenza
Mount Sinai Hospital, Canada 11
Testing effectiveness (Phase 2)Study completedNCT04782323
What this trial is testing

Safety and Immunogenicity of Different Formulations of an MF59-Adjuvanted Influenza Vaccine in Older Adults

Who this might be right for
Influenza
Seqirus 839
Post-approval studies (Phase 4)Study completedNCT01827462
What this trial is testing

Comparison of Immune Responses to Influenza Vaccine In Adults of Different Ages (SLVP015 2007-2017)

Who this might be right for
Influenza
Stanford University 136
Post-approval studies (Phase 4)Study completedNCT03344029
What this trial is testing

Immunogenicity and Safety of the Shenzhen Trivalent Inactivated Influenza Vaccine Versus a Trivalent Influenza Vaccine Comparator in Chinese Subjects 18 to 59 Years

Who this might be right for
InfluenzaFlu
Sanofi 1,600
Testing effectiveness (Phase 2)Study completedNCT04576702
What this trial is testing

Safety and Immunogenicity of an MF59-Adjuvanted Influenza Vaccine in Older Adults

Who this might be right for
InfluenzaHuman
Seqirus 471
Large-scale testing (Phase 3)Study completedNCT05308212
What this trial is testing

Tolerability, Safety and Immunogenicity Trial of the FLU-M® Tetra

Who this might be right for
Influenza
St. Petersburg Research Institute of Vaccines and Sera 633
Testing effectiveness (Phase 2)Study completedNCT00320346
What this trial is testing

Phase II Study of Pandemic Influenza Vaccine

Who this might be right for
Influenza
Seqirus 400
Testing effectiveness (Phase 2)Study completedNCT00006146
What this trial is testing

Half-Dose Flu Vaccine Study in Healthy Adults

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 840
Early research (Phase 1)Study completedNCT00664417
What this trial is testing

Study of Different Formulations of an Intramuscular A/H5N1 Inactivated, Split Virion Influenza Adjuvanted Vaccine

Who this might be right for
InfluenzaOrthomyxoviridae Infections
Sanofi 375
Post-approval studies (Phase 4)Study completedNCT03183908
What this trial is testing

FLUAD® vs. Fluzone® High-Dose Study

Who this might be right for
PainQuality of LifeInjection Site Reaction+2 more
Duke University 757
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation